Examination of Neisseria Gonorrhoeae Opacity Protein Expression During Experimental Murine Genital Tract Infection

Abstract

The opacity (Opa) proteins of Neisseria gonorrhoeae are a family of phasevariable outer membrane proteins that bind to host cells. Phase variable expression occurs via a reversible frameshift mechanism within each opa gene. Opa protein expression is selected for, or induced during experimental genital tract infection of female mice, similar to that which was reported in male volunteers. Using a genetically marked strain of FA1090 to follow recovery of a specific population of Opa variants during murine infection, here we showed that selection of a pre-existing population of Opa-positive gonococci present in the inoculum was responsible for the reisolation of mainly Opa-positive variants early during infection. We conclude that the preferential recovery of Opa-positive gonococci observed early during murine infection is due to selection of a pre-existing population of Opa-positive variants caused by factors other than binding to human CEACAM receptors. In long-term infection of mice, a cyclical pattern of Opa protein expression was observed in which a decreased recovery of Opapositive variants followed early selection for Opa protein expression; reemergence of Opa-positive gonococci occurred later in infection.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2005
Accession Number
ADA435969

Entities

People

  • Amy N. Simms

Organizations

  • Uniformed Services University of the Health Sciences

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Amino Acids
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antigens
  • Bacteria
  • Biomedical And Dental Materials
  • Blood
  • Cell Line
  • Cells
  • Chemistry
  • Epithelial Cells
  • Genetic Variation
  • Infection
  • Microbiology
  • Polymerase Chain Reaction
  • Polymeric Films
  • Sodium Compounds

Fields of Study

  • Biology

Readers

  • Immunology and Pathology
  • Microbial Pathology
  • Neurological Diseases/Conditions/Disorders

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech